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Abstract
Background: Care consistent with preferences is the goal of advance care planning (ACP). However, com-
paring written preferences to actual end-of-life care may not capture consistency of care with preferences.
Objective:We evaluated four additional types of consistency, using prospective data on written preferences and
active clinical decision making by patients and their surrogates.
Methods: Secondary analysis of data was done from a trial of an ACP intervention for patient-surrogate dyads.
Forty-five patients died during the trial and comprised the sample for the analysis. Sources of data included
patients’ preferences in a written goals-of-care tool, medical record reviews, and two-week postbereavement
interviews with surrogates to complement medical record reviews.
Results: Twenty-four patients (53.3%) received care consistent with written preferences and 11 (24.4%) in-
consistent with written preferences. The remaining 10 patients (22.2%) died suddenly with no opportunity for
treatment decision making. Eleven (24.4%) were able to participate in decision making with their surrogates; of
those, 9 (81.8%) received care consistent with their expressed preferences. Twenty-two patients were inca-
pacitated and thus the surrogate made treatment decisions alone; of those, 18 (81.8%) made decisions consistent
with the patient’s written preference.
Conclusions: Simply comparing documented preferences for end-of-life care and medical records of care
delivered does not adequately reflect the process of ACP and treatment decision making at the end of life. To
understand consistency between preferences and end-of-life care, investigators need data on written and real-
time expressed preferences.
Introduction
Advance care planning (ACP) in which patients andsurrogates discuss and document preferences for treat-
ment in future health states1,2 has been recognized as a way to
promote end-of-life care that is consistent with patients’
preferences.3,4 Several studies have examined whether an
ACP intervention promotes consistency between a patient’s
preferences and the treatments the patient actually receives
near the end of life.5–8 How such consistency was concep-
tualized and determined varied across the studies; in general a
patient’s early documented preferences were compared to
medical record documentation of the end-of-life care the
patient received (e.g., ICU admissions, CPR, mechanical
ventilation, and location of death).
Unfortunately, this way of determining consistency be-
tween preferences and end-of-life care reflects a limited as-
pect of treatment decisions at the end of life and may fail to
capture ACP as a process unfolding over several time points.
Consider situations wherein the patient is able to make his or
her own decisions up until the point of death. In such situa-
tions, the patient’s decisions may differ from his or her pre-
viously documented preferences. Also consider cases
wherein the surrogate makes decisions that honor the pa-
tient’s previously stated wishes, but the care team discounts
the surrogate’s decision. In the former case, delivered care
would be determined as having been inconsistent with the
patient’s documented preferences, when in fact it was con-
sistent with the patient’s most recently expressed preference.
In the latter case, care would also be determined as being
1Center for Nursing Excellence in Palliative Care, Nell Hodgson Woodruff School of Nursing, Emory University, Atlanta, Georgia.
2School of Nursing, University of Wisconsin-Madison, Madison, Wisconsin.
3School of Medicine, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina.
4School of Nursing, University of Virginia, Charlottesville, Virginia.
5School of Nursing, Kyungpook National University, Daegu, Korea.
Accepted December 31, 2015.
JOURNAL OF PALLIATIVE MEDICINE
Volume 19, Number 6, 2016
ª Mary Ann Liebert, Inc.
DOI: 10.1089/jpm.2015.0349
610
inconsistent, but an important distinction would have been
lost: whether the surrogate or the care team was dishonoring
the patient’s preferences.
To add further complexity, while a patient’s election of a
do-not-resuscitate (DNR) order allows for a relatively clear-
cut consistency determination (with the medical record re-
vealing that CPR was performed or not),8 most end-of-life
preferences are not so simple. End-of-life preferences are
commonly stated in terms of goals of care or as an over-
arching value in favor of either comfort care or aggressive
treatments. Such preferences often leave a great deal of room
for debate as to whether care was consistent with a patient’s
wishes. Despite these complexities, there have been few
discussions about how to define and measure consistency
between patient preferences and treatment decisions at the
end of life.
The purpose of this analysis was to examine several types
of consistency by comparing surrogate treatment decisions
and treatment actually received with patients’ previously
expressed written preferences. We used data from 45 patients
who died during a longitudinal trial of an ACP intervention
and their surrogates.
Methods
Study design
The present study is a secondary analysis of data from a
larger trial that tested the efficacy of an ACP intervention on
patient and surrogate preparation for end-of-life decision
making and postbereavement outcomes for surrogates. Dur-
ing the original study, patients and surrogates completed
measures of preparedness outcomes at baseline and 2, 6, and
12 months later, and surrogates completed measures of be-
reavement outcomes at baseline, 2 weeks, and 3 and 6months
after the patient’s death. Details of the study design have been
described elsewhere.9 For the purpose of this descriptive
analysis, the data from the intervention and control groups
were combined.
Setting and participants
The original study included 210 dyads of patients from 20
free-standing outpatient dialysis centers in eight counties in
North Carolina and their surrogates, who met the following
inclusion criteria: age 18 years or older; self-identified Af-
rican American or white; on dialysis for at least six months
prior to enrollment; Charlson Comorbidity Index (CCI)10
score ‡6 or CCI score = 5 and hospitalization in the last six
months; English speaking; no hearing impairment; < 3 errors
on the Short Portable Mental Status Questionnaire11; and an
English-speaking surrogate over age 18 who could partici-
pate. Of the 210 patients, 45 died during the study and
comprised the subgroup for this analysis.
Patient end-of-life preferences measured
Patients completed the goals-of-care tool12 as an out-
come measure at baseline and 2, 6, and 12 months or until
death. This tool included two scenarios describing medical
conditions that commonly occur in dialysis patients. In the
first, the patient developed a severe complication and
could not speak for him or herself; the medical team be-
lieved recovery unlikely and continuing life-sustaining
treatment, including dialysis, would no longer be benefi-
cial. In the second scenario, the patient developed ad-
vanced dementia. Each scenario had three response
options: ‘‘The goals of care should focus on delaying my
death, and thus I want to continue life-sustaining treat-
ment’’; ‘‘The goals of care should focus on my comfort
and peace, and thus I do not want life-sustaining treat-
ment, including dialysis’’; and ‘‘I am not sure.’’ For the
current analysis, the two responses in the last completed
goals-of-care tool prior to death were combined to create
an overarching goals-of-care preference: comfort care only
if the patient chose comfort care only for both scenarios,
or not comfort care only if the patient chose treatment
focused on delaying death for both scenarios or the re-
sponses were mixed or included ‘‘unsure.’’
End-of-life care data
During the original study, patients’ medical records at the
dialysis center and hospital were reviewed every two weeks
until the patient’s death or study end. Data on primary acute
medical conditions causing hospital admissions and treat-
ments were collected. Upon the patient’s death, the surrogate
was interviewed at two-week postbereavement to ask about
the patient’s last month prior to death and the surrogate’s end-
of-life experiences. These interviews complemented medical
record reviews in cases where the medical record provided
incomplete data (e.g., whether the surrogate was involved in
treatment decision making). An Excel spreadsheet was cre-
ated to display mortality data and treatment decisions chro-
nologically.
Types of consistency
Three authors (MS, SW, and LH) initially reviewed the
Excel spreadsheet to identify possible types of consistency
determination. The common approach to consistency de-
termination is: (1) Comparing the patient’s preference and
end-of-life care received. As Figure 1 presents, we defined
four additional types of consistency determination de-
pending on whether an acute medical condition/planned
procedure led to sudden death, or if instead there was an
opportunity for the patient and/or surrogate to be involved
in treatment decision making. In the case of sudden death,
there would be no possible consistency determination. If
the patient was able to participate in decision making and a
surrogate made decisions jointly with the patient, then
three types of consistency could exist; (2) consistency is
determined between the patient’s decisions while facing
end of life and last goals-of-care preference (i.e., a com-
parison between the patient’s verbal expression of pref-
erence at the end of life and his or her written preference
expressed on the goals-of-care tool); (3) Consistency is
determined between the patient’s verbally expressed de-
cisions while facing end of life and the surrogate’s later
decisions to honor the patient’s decisions; and (4) Con-
sistency is determined between the patient’s verbally ex-
pressed decisions while facing end of life and the care the
patient received. If the patient was incapacitated and the
surrogate made decisions without the patient, then (5)
consistency between the patient’s last written goals-of-care
preference and the surrogate’s decisions could be deter-
mined. A surrogate’s decisions inconsistent with the
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patient preference might result in end-of-life care incon-
sistent with the patient preference.
The three authors independently reviewed five randomly
selected cases to determine the types of end-of-life decision
making and consistency (consistent or inconsistent or un-
certain due to lack of data). Any discrepancies among the
authors were discussed for resolution and decision rules were
developed. Three additional cases were reviewed by MS,
SW, and LH to apply the decision rules. The decision rules
were refined before being used by three authors (MS, MM,
and SK) who independently determined the pathways and
consistency for all 45 cases. Any discrepancies were resolved
by group consensus. Descriptive statistics were used to
summarize the study variables. Types of consistency were
summarized using frequencies and percentages with 95%
confidence intervals.
Results
Sample characteristics
African Americans comprised slightly over 50% of the
subsample (n= 24 dyads, 53.3%). Roughly half of the pa-
tients (n= 21, 46.7%) and a majority of the surrogates (n = 34,
75.6%) were women (see Table 1). All but one patient were
on chronic hemodialysis prior to death.
End-of-life care
All 45 deaths occurred after an acute medical condition
or a planned procedure (see Table 2). The most frequent
acute condition was cardiovascular, such as heart attack or
stroke. A median of six days elapsed from the acute
condition or procedure to death. Thirty-four patients
(75.6%) were admitted to the hospital for the acute con-
dition. Half of all decedents received ICU care (n = 22,
48.9%). Only a small percentage of the patients received
palliative care or hospice care before death (n = 8, 17.8%),
and a majority (n = 31, 68.9%) died in the hospital or in a
skilled nursing facility.
Consistency between written preferences
and end-of-life care
A majority of the patients’ overarching goals-of-care
preference was comfort care only (n = 30, 66.7%) (see
Type of consistency determination
A. Common determination 1. Consistency between the patient’s last written goals-of-care preference
and end-of-life care the patient received
B. SPIRIT trial
Surrogate decision making with patient
(as they actually face end of life)
2. Consistency between the patient’s decisions at the end of life and his/her
last written goals-of-care preference
3. Consistency between the patient’s decisions at the end of life and the
surrogate’s decisions
4. Consistency between the patient’s decisions at the end of life and end-of-
life care the patient received
Surrogate decision making without patient 5. Consistency between the patient’s last written goals-of-care preference
and the surrogate’s decisions
SPIRIT, Sharing the Patient’s Illness Representations to Increase Trust.
FIG. 1. Common way of consistency determination (A) and four additional types of consistency determination in the
SPIRIT trial (B). (AD, advance directive.)
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Table 3). The last completion of the goals-of-care tool oc-
curred a median of three months prior to death. Using the first
definition of consistency, end-of-life care was consistent with
written preferences for 24 (53.3%) patients and inconsistent
for 11 (24.4%). Ten patients (22.2%) died suddenly at home
or in a nursing or dialysis facility, leaving no opportunity for
treatment decision making, and thus consistency could not be
determined.
Consistency using additional information
on decision making
Of the 45 cases, 11 acutely ill patients (24.4%) were able to
participate in their own medical decisions with their surro-
gates, and 22 surrogates (48.9%) made treatment decisions
without the patient due to the patient’s incapacitation. There
were two cases (4.4%) for which a decision-making process
could not be determined due to lack of data as to who made
the decision.
Of the 11 patients who were able to participate in their own
medical decisions with their surrogates, 7 patients (63.6%)
made decisions consistent with their last written goals-of-
care preference (consistency type 2), whereas 4 (36.4%)
made decisions that differed from their written preferences.
Of these 11 patients, choices made by 9 surrogates (81.8%)
were consistent with the patient’s expressed treatment choi-
ces (consistency type 3), and 9 patients (81.8%) received
actual end-of-life care consistent with choices expressed
during acute illness (consistency type 4). Finally, of the 22
cases in which the surrogate made treatment decisions alone,
surrogates’ decisions were consistent with the patient’s
preference indicated in the last written goals-of-care tool
(consistency type 5) in 18 cases (81.8%).
Discussion
We examined several ways to define consistency between
patient preferences and treatment decisions at the end of
life. The patient’s preference expressed in the goals-of-care
tool and end-of-life care received were consistent for
roughly half of the sample. Several additional consistency
Table 1. Baseline Characteristics of Patients
and Surrogates
Characteristic
Participants, n (%)a
Patient
(N = 45)
Surrogate
(N = 45)
Sociodemographics
Age, mean (SD), years 64.4 (12.6) 57.1 (13.7)
Women 21 (46.7) 34 (75.6)
Black, raceb 24 (53.5) 24 (53.5)
Formal education completed,
mean (SD), years
12.9 (3.4) 13.6 (2.6)
Protestant, religion 36 (80.0) 36 (80.0)
Annual income
<$20,000 20 (44.4) 11 (24.4)
$20,000 – $50,000 18 (40.0) 18 (40.0)
> $50,000 6 (13.3) 13 (28.9)
Declined to answer 1 (2.2) 3 (6.7)
Surrogate’s relationship
to patient
Spouse/partner - 18 (40.0)
Parent - 13 (28.9)
Sibling - 6 (13.3)
Child - 3 (6.7)
Friend - 3 (6.7)
Other - 2 (4.4)
Patient medical
Hemodialysis 44 (97.8) -
Years on dialysis, mean (SD) 4.9 (4.4) -
CCI, mean (SD) 8.8 (1.8) -
Has an AD 16 (35.6) -
DNR order at the clinic 8 (17.8) -
aDue to rounding, percentages may not sum to 100.
bSelf-identified.
AD, advance directive; CCI, Charlson Comorbidity Index. DNR,
do-not-resuscitate.
Table 2. Care Near the End of Life (N= 45)
Variable Participants, n (%)a
Primary acute medical condition or procedure preceding
death
Heart attack or stroke 18 (40.0)
Infection 7 (15.6)
Failure to thrive 4 (8.9)
GI problems (e.g., bleeding,
ischemic bowel)
4 (8.9)
Surgery or procedure (e.g.,
amputation)
4 (8.9)
Fall 3 (6.7)
Fistula/graft complication 3 (6.7)
Exacerbation of other chronic
condition (e.g., heart failure)
2 (4.4)
Survival time since randomization, months
Median (IQR) 8.0 (5.5–18.0)
Mean (SD) 12.0 (9.8)
Survival time since acute medical condition
or procedure, days
Median (IQR) 6.0 (2.0–10.0)
Mean (SD) 9.0 (12.8)
Care following acute medical
condition
Hospital admission 34 (75.6)
Length of hospital stay, days
Median (IQR) 5.0 (0.5–9.5)
Mean (SD) 8.0 (13.1)
ICU admission 22 (48.9)
Length of ICU stay, days
Median (IQR) 0.5 (0–4.8)
Mean (SD) 4.6 (12.6)
CPR 16 (35.6)
Palliative care or hospice use 8 (17.8)
Location of death
ICU 17 (37.8)
Other unit in the hospital 11 (24.4)
Skilled nursing facility 3 (6.7)
Hospice unit 4 (8.9)
Home 10 (22.2)
aDue to rounding, percentages may not sum to 100.
IQR, interquartile range; GI, gastrointestinal; ICU, intensive care
unit; CPR, cardiopulmonary resuscitation.
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determinations revealed that, in the cases wherein the pa-
tient was able to participate in treatment decision making up
until death, end-of-life care received was consistent with the
patient’s decisions for a majority of the patients (81.8%).
When surrogates made treatment decisions at the end of life
without the patient because of the patient’s incapacitation, a
majority (81.8%) were determined to be consistent. Thus,
real-time decision making sometimes superseded written
preferences, and insight into this process resulted in higher
rates of consistency.
Emanuel and Scandrett13 have argued that the match
(consistency) between a patient’s goals and the care he or she
received should be the gold standard for quality of palliative
care. For this important benchmark of palliative care, our
study raises an important issue: only comparing a docu-
mented patient preference with delivered care may be too
limited to appropriately reflect the actual treatment decision-
making process at the end of life. Previous efforts to assess
consistency typically involved comparing the patient’s
medical records of delivered end-of-life care with the pa-
tient’s preferences that had been documented immediately
after an ACP discussion or an AD that was completed at some
point in the past. This approach assumes that documented
preferences are the patient’s fixed decisions, when in fact
there can be an important time interval between preference
statements and treatment. Real-time decisions likely incor-
porate new information that patients do not have when
completing ADs.
Therefore, we examined end-of-life care consistency from
a perspective that goes beyond those efforts by examining
patients’ preferences that were elicited most recently prior to
death and later verbal preferences in comparison with sur-
rogates’ decisions and end-of-life care the patient received.
Consistency between the patient’s decisions and last written
goals-of-care preference differs from the other types of
consistency as it is a within-patient comparison. However, it
was a meaningful determination because it revealed an im-
portant minority of patients was able to participate in decision
making up until the point of death, and some of those deci-
sions differed from their previously expressed preferences.
For these patients, delivered end-of-life care was inconsistent
with their preferences indicated in the goals-of-care tool,
while clearly reflecting an autonomous patient’s decisions at
that time.
Differentiating types of consistency can be important for
improving end-of-life care, because such differentiation may
reveal specific problems that undermine quality of end-of-life
care. For example, without a determination of the consistency
between surrogate decisions and patient preference, it would
be unclear whether an inconsistency of delivered end-of-life
Table 3. Consistency between Patient’s Preferences and Treatment Decisions (N= 45)
Variable Participants, n (%, 95% CI)a
Time between the last completed goals-of-care preference and death, month
Median (IQR) 3.0 (1.0–6.0)
Mean (SD) 5.2 (6.7)
Preference expressed in the last goals-of-care toolb
Comfort care only 30 (66.7, 52.9–80.5)
Not comfort care only 15 (33.3, 19.5–47.1)
Consistency type
1. Consistency between last written goals-of-care preference and end-of-life care received
Consistent 24 (53.3, 38.8–67.9)
Inconsistent 11 (24.4, 11.9–37.0)
Uncertain due to sudden death 10 (22.2, 10.1–34.3)
Surrogate decision making with patient (n= 11)
2. Consistency between the patient’s decisions at the end of life and last written
goals-of-care preference
Consistent 7 (63.6, 35.2–92.0)
Inconsistent 4 (36.4, 8.0–64.8)
3. Consistency between the patient’s decisions at the end of life and surrogate’s decisions
Consistent 9 (81.8, 59.0–100.0)
Inconsistent 2 (18.2, 0–41.0)
4. Consistency between the patient’s decisions at the end of life and end-of-life care received
Consistent 9 (81.8, 59.0–100.0)
Inconsistent 2 (18.2, 0–41.0)
Surrogate decision making without patient (n = 22)
5. Consistency between the patient’s last written goals-of- care preference
and the surrogate’s decisions
Consistent 18 (81.8, 65.7–97.9)
Inconsistent 4 (18.2, 2.1–34.3)
aDue to rounding, percentages may not sum to 100.
bBased on the last completed goals-of-care tool prior to death: comfort care only if the patient chose comfort care only for both scenarios;
not comfort care only if the patient chose delaying death for both scenarios or the responses were mixed or included unsure.
IQR, interquartile range.
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care was due to the surrogate not fulfilling his or her role
(possibly due to ineffective ACP) or rather to the care team’s
failure to honor the surrogate’s decision. While delivered
end-of-life care was consistent with the patient’s preference
for only 53% of the patients, 82% of the surrogates made
treatment decisions that were consistent with the patient’s
preference or decisions.
Although sudden deaths are not uncommon among pa-
tients with serious chronic illness, such as dialysis patients,
the role of sudden deaths in consistency determination has
not been discussed previously. Slightly over 20% of the
sample in our study and a similar percentage in a study by
Detering et al.5 died suddenly. These sudden deaths included
cases, for example, of unwitnessed death at home, and car-
diac arrest at a nursing facility or dialysis center leading to
death before any treatment could be given other than CPR. If
our study had been focused on CPR preference only, we
might have been able to determine consistency for these
cases. However, we were looking beyond CPR preferences.
Therefore, instead of making consistency determinations
with little to no information about treatment decisions, we
decided to distinguish cases of sudden death from cases
where there was sufficient information to make a consistency
determination.
Judgment calls are unavoidable in consistency determi-
nation, because what treatment should or should not be pro-
vided for a patient who has chosen comfort care only can be
highly situational.8 For example, some patients who desire
comfort care only may require hospital admission if comfort
care cannot be provided in the patient’s current location.
Also, code status is not predictive of a patient’s preferences
for other kinds of treatments at the end of life; patients with a
DNR order often want other aggressive treatments at the end
of life.14 This matter adds to the complexity in consistency
determination especially for dialysis patients, because code
status at the dialysis center is made separately from and can
be different from one made at the hospital.
In our study, care received following an acute medical
condition was very similar to end-of-life care observed in a
national sample.15 In the national sample, 76.0% experienced
hospitalization and 48.9% received ICU care during the final
month of life, and 44.8% died in a hospital.15 Even though
66.7% of our sample chose comfort care only in the event of
an irreversible life-threatening complication, such prefer-
ences did not change the course after an acute medical con-
dition for many patients. This might be associated with the
fact that in the U.S. health care system, patients have little
choice but to visit a hospital to manage an acute illness.3
Because numerous factors can affect end-of-life care con-
sistency, it would be important that studies involving con-
sistency determination make a concerted effort to minimize
judgment calls and clearly describe the procedures employed
for determination. Further, medical record reviews alone
would be limited to reveal the complexity of treatment de-
cision making at the end of life, and an additional source of
information to complement medical record data would be
necessary.
Our study findings are exploratory in nature because of the
small sample and the small number of observations for in-
dividual consistency types. Also, the original study was
conducted in a single region of the Unted States. The path-
ways after an acute illness and the four additional forms of
consistency determination in the study were based on what
was observed in the sample, and thus may not be inclusive of
all possible ways of defining consistency. Nonetheless, our
analysis revealed several important aspects of end-of-life
care consistency determination that may inform future
research.
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